Free Trial
OTCMKTS:NGENF

NervGen Pharma (NGENF) Stock Price, News & Analysis

NervGen Pharma logo
$2.27 +0.18 (+8.61%)
As of 03:58 PM Eastern

About NervGen Pharma Stock (OTCMKTS:NGENF)

Key Stats

Today's Range
$2.09
$2.34
50-Day Range
$1.81
$2.27
52-Week Range
$1.20
$2.42
Volume
172,400 shs
Average Volume
53,639 shs
Market Capitalization
$140.22 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

NervGen Pharma Corp., together with its subsidiaries, engages in the discovery, development, and commercialization of pharmaceutical treatments for medical conditions related to nervous system damage. The company's lead product candidate is NVG-291 that is in Phase 1b/2a clinical trial for the treatment of spinal cord injuries (SCI), multiple sclerosis, and Alzheimer's disease. It has a licensing agreement with Case Western Reserve University to research, develop, and commercialize a patented technology with therapeutic potential for spinal cord injury and other conditions associated with nerve damage. The company was incorporated in 2017 and is based in Vancouver, Canada.

Remove Ads
Receive NGENF Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for NervGen Pharma and its competitors with MarketBeat's FREE daily newsletter.

NGENF Stock News Headlines

NervGen Pharma to Host Virtual Investor Event
NervGen Pharma price target raised to C$4.50 from C$3 at Raymond James
“Fed Proof” Your Bank Account with THESE 4 Simple Steps
Starting as soon as a few months from now, the United States government will make a sweeping change to bank accounts nationwide. It will give them unprecedented powers to control your bank account.
NervGen upgraded to Outperform from Market Perform at Raymond James
See More Headlines

NGENF Stock Analysis - Frequently Asked Questions

NervGen Pharma's stock was trading at $2.18 at the beginning of the year. Since then, NGENF shares have increased by 4.1% and is now trading at $2.27.
View the best growth stocks for 2025 here
.

Shares of NGENF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Company Calendar

Today
4/02/2025
Next Earnings (Estimated)
4/15/2025

Industry, Sector and Symbol

Stock Exchange
OTCMKTS
Sector
Medical
Industry
Biotechnology
Sub-Industry
N/A
Current Symbol
OTCMKTS:NGENF
CIK
N/A
Web
N/A
Fax
N/A
Employees
7
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
$-4,070,000.00
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
$150,000.00
Price / Cash Flow
N/A
Price / Book
N/A

Miscellaneous

Free Float
N/A
Market Cap
$140.22 million
Optionable
Not Optionable
Beta
N/A
The 10 Best AI Stocks to Own in 2025 Cover

Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.

Get This Free Report

This page (OTCMKTS:NGENF) was last updated on 4/2/2025 by MarketBeat.com Staff
From Our Partners